Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» SHP465
SHP465
A decade behind schedule, Shire finally gets an FDA OK for long-acting ADHD drug
Endpoints
Wed, 06/21/17 - 09:50 am
Shire
FDA
ADHD
Mydayis
SHP465
Shire finally finishes a 10-year trek back to the FDA with an old ADHD drug
Endpoints
Thu, 01/19/17 - 11:49 am
Shire
FDA
ADHD
SHP465
Shire looks for more ADHD mileage with new data on long-acting prospect
Fierce Pharma
Wed, 07/6/16 - 09:53 am
Shire
ADHD
SHP465
Shire's adult ADHD drug shows promise in late-stage study
BioPharma Dive
Fri, 07/1/16 - 09:44 am
Shire
ADHD
SHP465
clinical trials
Shire bullish on 2017 approval of new, longer-lasting ADHD pill
BioPharma Dive
Wed, 04/8/15 - 10:49 am
Shire
ADHD
SHP465
Shire agrees regulatory path for ADHD drug for adults
Yahoo/Reuters
Tue, 04/7/15 - 10:11 am
Shire
ADHD
SHP465